Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 11—November 2022
Research

Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant

Ana Maria Quintero, Mariah Eisner, Rouba Sayegh, Tori Wright, Octavio Ramilo, Amy L. Leber, Huanyu Wang1Comments to Author , and Asuncion Mejias1Comments to Author 
Author affiliations: Nationwide Children’s Hospital, Columbus, Ohio, USA (A.M. Quintero, R. Sayegh, T. Wright, O. Ramilo, A.L. Leber, H. Wang, A. Mejias); Biostatistics Resource at Nationwide Children’s Hospital, Columbus (M. Eisner); The Ohio State University, Columbus (M. Eisner, O. Ramilo, H. Wang, A. Mejias)

Main Article

Figure 3

Distribution of SARS-CoV-2 variants pediatric and adolescent patients included in a clinical cohort (n = 676) at Nationwide Children’s Hospital, Columbus, Ohio, USA, by age group. Bars represent the percentage of each SARS-CoV-2–specific variant in the different age groups.

Figure 3. Distribution of SARS-CoV-2 variants pediatric and adolescent patients included in a clinical cohort (n = 676) at Nationwide Children’s Hospital, Columbus, Ohio, USA, by age group. Bars represent the percentage of each SARS-CoV-2–specific variant in the different age groups.

Main Article

1These authors contributed equally to and co-directed this work.

Page created: October 06, 2022
Page updated: October 21, 2022
Page reviewed: October 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external